Studying individual causal effects of health interventions is of interest whenever intervention effects are heterogeneous between study participants. Conducting N-of-1 trials, which are single-person randomized controlled trials, is the gold standard for their analysis. In this study, we propose to re-analyze existing population-level studies as N-of-1 trials as an alternative, and we use gait as a use case for illustration. Gait data were collected from 16 young and healthy participants under fatigued and non-fatigued, as well as under single-task (only walking) and dual-task (walking while performing a cognitive task) conditions. We first computed standard population-level ANOVA models to evaluate differences in gait parameters (stride length and stride time) across conditions. Then, we estimated the effect of the interventions on gait parameters on the individual level through Bayesian linear mixed models, viewing each participant as their own trial, and compared the results. The results illustrated that while few overall population-level effects were visible, individual-level analyses showed nuanced differences between participants. Baseline values of the gait parameters varied largely among all participants, and the changes induced by fatigue and cognitive task performance were also highly heterogeneous, with some individuals showing effects in opposite direction. These differences between population-level and individual-level analyses were more pronounced for the fatigue intervention compared to the cognitive task intervention. Following our empirical analysis, we discuss re-analyzing population studies through the lens of N-of-1 trials more generally and highlight important considerations and requirements. Our work encourages future studies to investigate individual effects using population-level data.
Hasso Plattner Institute for Digital Engineering(数字工程哈索·普拉特纳研究所);University of Potsdam(波茨坦大学);École Polytechnique Fédérale de Lausanne(洛桑联邦理工学院);CUNY Graduate School of Public Health and Health Policy(纽约市立大学研究生院公共卫生与健康政策学院)
On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
Yale University(耶鲁大学);Mississippi State University(密西西比州立大学);Hospital of the University of Pennsylvania(宾夕法尼亚大学医院);Perelman School of Medicine at the University of Pennsylvania(宾夕法尼亚大学佩雷尔曼医学院);Ottawa Hospital Research Institute(渥太华医院研究所);University of Ottawa(渥太华大学)
Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
Advanced Methodology and Data Science, Novartis Pharma AG(诺华制药AG高级方法与数据科学);China Novartis Institutes for Bio-medical Research CO.(中国诺华生物医学研究院有限公司);Advanced Methodology and Data Science, Novartis Pharmaceuticals Corporation(诺华制药有限公司高级方法与数据科学);Department of Statistics, Stanford University(斯坦福大学统计学系)
Causally-interpretable meta-analysis using aggregate data
University of Groningen(格罗宁根大学);University Medical Center Utrecht(乌得勒支大学医学中心);University Medical Center Groningen(格罗宁根大学医学中心);Groningen Research Institute of Pharmacy(格罗宁根药学研究所);Dutch National Institute of Public Health and the Environment (RIVM)(荷兰国家公共卫生与环境研究所(RIVM));Harvard T.H. Chan School of Public Health(哈佛大学陈曾熙公共卫生学院)
Using Targeted Maximum Likelihood Estimation to Estimate Treatment Effect with Longitudinal Continuous or Binary Data: A Systematic Evaluation of 28 Diabetes Clinical Trials